Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2026-04-08 @ 11:56 PM
Study NCT ID:
NCT01788020
Status:
COMPLETED
Last Update Posted:
2024-05-13
First Post:
2013-02-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia
Sponsor:
University of Ulm
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-11
Start Date Type:
None
Primary Completion Date:
2018-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04
Completion Date Type:
ACTUAL
First Submit Date:
2013-02-01
First Submit QC Date:
None
Study First Post Date:
2013-02-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-10
Last Update Post Date:
2024-05-13
Last Update Post Date Type:
ACTUAL